Nicholas Goldner, PhD, is the CEO and co-founder of resistanceBio, where he leads a mission to outsmart cancer by developing innovative therapies targeting treatment resistance mechanisms. He also serves as a venture partner at Pioneer...

Dr. Lewis is the Bird Dogs Chair in Translational Oncology at the University of Alberta in Edmonton, Alberta. As a scientist and serial entrepreneur, he pioneered the use of intravital imaging in the in vivo...

Michael Levin is a biologist at Tufts University working on novel ways to understand and control complex pattern formation in biological systems. Michael Levin links Michael’s Twitter: https://twitter.com/drmichaellevin Michael’s Website: https://drmichaellevin.org PODCAST INFO: The Learning...

Resistance resistance cancer therapies that last longer and hit harder. This is what Nick and Chris from Visoera are currently working on. They’ve been funded, been through YC, and are two amazing scientists turned entrepreneurs....

Prior to Genomic Expression, she founded Proximity Venture Advisors, an international business consulting company that serves high tech companies within the Life Science sector. She worked with biotech companies securing licensing deals, reference clients and capital. Her deal resume is north of $1 billion.